Fundz

Who to call at Creatv MicroTech, and when

Fundz watches for the moments Creatv MicroTech starts buying, and tells you who to reach.

  • An alert the day Creatv MicroTech raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Creatv MicroTech, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Creatv Bio and Neovia Oncology Form Strategic Partnership to Combat Multiple Drug Resistance in Cancer.

Jun 02, 2026

Contract Type

partnership

MarylandBiotechnologyHealth CareMedicalTherapeuticsHealth Diagnostics

Description

Creatv Bio has partnered with Neovia Oncology to collaborate on studies for patients with advanced drug-resistant solid tumors. The partnership aims to enhance patient stratification and understand treatment responses better.

Company Information

Company

Creatv MicroTech

Location

Maryland, United States

About

Creatv MicroTech is a microfabrication company that focuses on advanced cancer diagnostics and screening technologies. Founded in 2010, the company developed a microfilter designed to capture circulating tumor cells from cancer patients' blood. Their revolutionary LifeTracDx® blood test provides valuable insights for cancer diagnosis and treatment. The company’s work, especially the development of cancer associated macrophage-like cells (CAMLs), has transformed cancer care.

Predictive Intelligence
Strategic

ML-powered predictions for Creatv MicroTech's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Creatv MicroTech signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.